Reversir Trademark Details

This mark is alive with a status of Suspension Letter - Mailed. The last case file activity for this mark occured 7 years ago on Tuesday, August 2, 2016, according to the United State Patent & Trademark Office
Word Mark Reversir
Status Alive 653 — Suspension Letter - Mailed

Current Owner

Alnylam Pharmaceuticals Inc of Cambridge, MA

View all trademarks for Alnylam Pharmaceuticals Inc
Other Trademarks for Alnylam Pharmaceuticals Inc
Serial Number 86776831
Status Date Tuesday, August 2, 2016
Filing Date Tuesday, August 2, 2016
Attorney Ann Lamport Hammitte

Correspondent

ANN LAMPORT HAMMITTE
LANDO & ANASTASI, LLP
ONE MAIN STREET
CAMBRIDGE, MA 02142

Case File Statements

Goods & Services pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Wednesday, October 7, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.